These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 11381099

  • 1. Pneumococcal virulence factors: structure and function.
    Jedrzejas MJ.
    Microbiol Mol Biol Rev; 2001 Jun; 65(2):187-207 ; first page, table of contents. PubMed ID: 11381099
    [Abstract] [Full Text] [Related]

  • 2. [Proteins of Streptococcus pneumoniae: perspectives for development of pneumococcal vaccine].
    Vorob'ev DS, Semenova IB, Kurbatova EA.
    Zh Mikrobiol Epidemiol Immunobiol; 2010 Jun; (6):98-104. PubMed ID: 21384595
    [Abstract] [Full Text] [Related]

  • 3. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins.
    Paton JC, Andrew PW, Boulnois GJ, Mitchell TJ.
    Annu Rev Microbiol; 1993 Jun; 47():89-115. PubMed ID: 7903033
    [Abstract] [Full Text] [Related]

  • 4. Molecular and cellular biology of pneumococcal infection.
    Tuomanen E.
    Curr Opin Microbiol; 1999 Feb; 2(1):35-9. PubMed ID: 10047549
    [Abstract] [Full Text] [Related]

  • 5. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.
    Cockeran R, Anderson R, Feldman C.
    Arch Immunol Ther Exp (Warsz); 2005 Feb; 53(3):189-98. PubMed ID: 15995579
    [Abstract] [Full Text] [Related]

  • 6. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection.
    Cockeran R, Anderson R, Feldman C.
    Curr Opin Infect Dis; 2002 Jun; 15(3):235-9. PubMed ID: 12015456
    [Abstract] [Full Text] [Related]

  • 7. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis.
    Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI.
    J Infect Dis; 2004 Nov 01; 190(9):1661-9. PubMed ID: 15478073
    [Abstract] [Full Text] [Related]

  • 8. Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis.
    Ng EW, Costa JR, Samiy N, Ruoff KL, Connolly E, Cousins FV, D'Amico DJ.
    Retina; 2002 Oct 01; 22(5):622-32. PubMed ID: 12441729
    [Abstract] [Full Text] [Related]

  • 9. Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage.
    López R, García E.
    FEMS Microbiol Rev; 2004 Nov 01; 28(5):553-80. PubMed ID: 15539074
    [Abstract] [Full Text] [Related]

  • 10. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies.
    Tai SS.
    Crit Rev Microbiol; 2006 Nov 01; 32(3):139-53. PubMed ID: 16893751
    [Abstract] [Full Text] [Related]

  • 11. Detection of pneumolysin and autolysin genes among antibiotic resistant Streptococcus pneumoniae in invasive infections.
    Sourav S, Patricia A, Sharma S, Kanungo R, Jayachandran S, Prashanth K.
    Indian J Med Microbiol; 2010 Nov 01; 28(1):34-9. PubMed ID: 20061761
    [Abstract] [Full Text] [Related]

  • 12. Pneumococcal conjugate vaccine for young children.
    Selman S, Hayes D, Perin LA, Hayes WS.
    Manag Care; 2000 Sep 01; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [Abstract] [Full Text] [Related]

  • 13. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
    Huo Z, Spencer O, Miles J, Johnson J, Holliman R, Sheldon J, Riches P.
    Vaccine; 2004 Mar 12; 22(9-10):1157-61. PubMed ID: 15003643
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of putative pneumococcal virulence proteins.
    Paton JC, Berry AM, Lock RA.
    Microb Drug Resist; 1997 Mar 12; 3(1):1-10. PubMed ID: 9109091
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.
    Ramos-Sevillano E, Urzainqui A, Campuzano S, Moscoso M, González-Camacho F, Domenech M, Rodríguez de Córdoba S, Sánchez-Madrid F, Brown JS, García E, Yuste J.
    Infect Immun; 2015 Feb 12; 83(2):591-603. PubMed ID: 25404032
    [Abstract] [Full Text] [Related]

  • 17. In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin.
    Le CF, Yusof MY, Hassan MA, Lee VS, Isa DM, Sekaran SD.
    Sci Rep; 2015 Jul 09; 5():11886. PubMed ID: 26156658
    [Abstract] [Full Text] [Related]

  • 18. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins.
    Berry AM, Paton JC.
    Infect Immun; 2000 Jan 09; 68(1):133-40. PubMed ID: 10603379
    [Abstract] [Full Text] [Related]

  • 19. Genetic diversity and antigenicity analysis of Streptococcus pneumoniae pneumolysin isolated from children with pneumococcal infection.
    Han C, Zhang M.
    Int J Infect Dis; 2019 Sep 09; 86():57-64. PubMed ID: 31255709
    [Abstract] [Full Text] [Related]

  • 20. Analysis of structure and function of putative surface-exposed proteins encoded in the Streptococcus pneumoniae genome: a bioinformatics-based approach to vaccine and drug design.
    Rigden DJ, Galperin MY, Jedrzejas MJ.
    Crit Rev Biochem Mol Biol; 2003 Sep 09; 38(2):143-68. PubMed ID: 12749697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.